MedTrace Logo

Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability

NCT00793026 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-12-19

No results posted yet for this study

Summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Conditions

  • Hygiene

Interventions

DRUG

Dermacyd Breeze Pocket BR (Lactic Acid)

Dermacyd Breeze Pocket BR (Lactic Acid) during 21 consecutive days

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2008-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00793026 on ClinicalTrials.gov